NFE2L2 and colonic neoplasm: Mechanistically, SFN demethylation modification at the CpG islands of Nrf2 promoter region, leading to upregulation of Nrf2 gene expression via modulation of the expression of DNA methyltransferases, exhibits anticancer potential in colon cancer [92] and skin neoplasm [62].